Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yonghong Liu

Showing results (631-640 of 648) with videos related to

Pageof 65
Sort By:
Acta Pharmaceutica Sinica. B|December 23, 2020
Targeting castration-resistant prostate cancer with a novel ROR<i>γ</i> antagonist elaiophylinJianwei Zheng, Junfeng Wang, Qian Wang, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 7, 2025
Transcutaneous auricular vagus nerve stimulation to treat narcolepsy type 1 (TARGET-NT1): A two-arm, randomised, sham-controlled trialYuanhang Pan, Yingchi Zhang, Ziliang Xu, et al.
Cell Death & Disease|February 20, 2022
Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancerLin Zhong, Bin Yang, Zhenhua Zhang, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2022
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in miceIrene González-Domínguez, Jose Luis Martínez, Stefan Slamanig, et al.
Developmental Cell|April 4, 2024
Telomere dysfunction alters intestinal stem cell dynamics to promote cancerKyle A LaBella, Wen-Hao Hsu, Jiexi Li, et al.
Nature Communications|August 27, 2020
Exposure to air pollution and scarlet fever resurgence in China: a six-year surveillance studyYonghong Liu, Hui Ding, Shu-Ting Chang, et al.
BMC Medicine|February 20, 2026
First-in-human phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors, including recurrent or metastatic HNSCCDongmei Ji, Wenmin Fu, Yonghong Liu, et al.
Science (New York, N.Y.)|April 3, 2020
An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in ChinaHuaiyu Tian, Yonghong Liu, Yidan Li, et al.
CNS Neuroscience & Therapeutics|April 16, 2022
Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open-label, randomized studyHaoyue Zhu, Xuejun Deng, Li Feng, et al.
Nature Communications|October 28, 2021
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responsesWeina Sun, Yonghong Liu, Fatima Amanat, et al.
Pageof 65

Showing results (631-640 of 648) with videos related to

Sort By:
Pageof 65
Acta Pharmaceutica Sinica. B|December 23, 2020
Targeting castration-resistant prostate cancer with a novel ROR<i>γ</i> antagonist elaiophylinJianwei Zheng, Junfeng Wang, Qian Wang, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 7, 2025
Transcutaneous auricular vagus nerve stimulation to treat narcolepsy type 1 (TARGET-NT1): A two-arm, randomised, sham-controlled trialYuanhang Pan, Yingchi Zhang, Ziliang Xu, et al.
Cell Death & Disease|February 20, 2022
Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancerLin Zhong, Bin Yang, Zhenhua Zhang, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2022
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in miceIrene González-Domínguez, Jose Luis Martínez, Stefan Slamanig, et al.
Developmental Cell|April 4, 2024
Telomere dysfunction alters intestinal stem cell dynamics to promote cancerKyle A LaBella, Wen-Hao Hsu, Jiexi Li, et al.
Nature Communications|August 27, 2020
Exposure to air pollution and scarlet fever resurgence in China: a six-year surveillance studyYonghong Liu, Hui Ding, Shu-Ting Chang, et al.
BMC Medicine|February 20, 2026
First-in-human phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors, including recurrent or metastatic HNSCCDongmei Ji, Wenmin Fu, Yonghong Liu, et al.
Science (New York, N.Y.)|April 3, 2020
An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in ChinaHuaiyu Tian, Yonghong Liu, Yidan Li, et al.
CNS Neuroscience & Therapeutics|April 16, 2022
Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open-label, randomized studyHaoyue Zhu, Xuejun Deng, Li Feng, et al.
Nature Communications|October 28, 2021
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responsesWeina Sun, Yonghong Liu, Fatima Amanat, et al.
Pageof 65